The Valley Desk

NCT02342704 · Interventional trial

Impact of Natalizumab Versus Fingolimod in Relapsing-Remitting Multiple Sclerosis (RRMS) Participants

Overall registry status Terminated

Phase 4

Conditions Relapsing-Remitting Multiple Sclerosis

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov